查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1715481

藥用輔料市場按類型、配方、功能和最終用戶分類—2025-2030 年全球預測

Pharmaceutical Excipient Market by Type, Formulation, Function, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年藥用輔料市場價值將達到86.2億美元，2024年將達到92.2億美元，複合年成長率為7.62%，到2030年將達到144.2億美元。

主要市場統計數據
基準年2023年 86.2億美元
預計2024年 92.2億美元
預測年份 2030 144.2億美元
複合年成長率（%） 7.62%

藥用輔料市場已發展成為一個充滿活力、多方面的生態系統，反映了技術創新、法規遵循和成本效益製造之間的微妙平衡。在當今的競爭格局中，輔料不僅僅是添加劑；它們是影響藥物製劑的功效、穩定性和整體品質的重要因素。在過去十年中，材料科學的進步、對活性藥物成分 (API) 相互作用的更深入理解以及對定製藥物輸送系統的穩定需求刺激了輔料領域的強勁成長和多樣化。

製造商和研究機構都不再局限於輔料的傳統作用，而是專注於複雜的工藝和品質標準。這一發展是技術進步、嚴格的標準化通訊協定和對永續性關注相結合的結果。隨著市場的發展，公司現在面臨的挑戰是在技術創新與滿足嚴格的監管控制之間取得平衡，以確保最終產品既安全又有效。本介紹全面深入探討了藥用輔料產業現狀的趨勢、細分策略、區域發展和主要參與者的亮點。

改變藥用輔料市場

藥用輔料市場正經歷變革時期，重塑產業動態並重新定義最佳實踐。生物技術研究的快速進步以及不斷發展的以患者為中心的需求正在催生出一種新環境，人們期望輔料能夠發揮超越其原始用途的多種功能。人們越來越關注以患者為中心的配方，這推動了對具有更好生物有效性、控制釋放特性和最小副作用的賦形劑的需求。

配方科學的技術突破使製造商能夠將傳統賦形劑與新型成分混合，從而創造出適用於不同治療領域的適應性更強的產品。此外，法規環境變得越來越嚴格，世界各地的監管機構都實施嚴格的品質和安全基準，使得輔料的選擇成為開發過程中的關鍵要素。更高標準的需求迫使製造商不斷創新並投資研發。

市場相關人員也因全球化而經歷顛覆性轉變，跨國夥伴關係和策略聯盟促進了知識交流並加強了供應鏈。在這些趨勢的背景下，市場格局正在快速發展，需要快速反應、策略夥伴關係和敏捷的決策流程來利用新的機會。

市場區隔洞察推動市場變革

藥用輔料領域的市場細分提供了多樣化產品範圍及其應用的詳細概況。基於類型的分割區分無機類別和有機類別。無機輔料分為碳酸鈣、磷酸鈣、硫酸鈣、鈣鹽和金屬氧化物等類型，每種輔料都有獨特的特性，可滿足特定的配方需求。相反，有機類別分為碳水化合物、油脂化學品、石化產品和蛋白質，說明了天然材料和合成材料的重要性。在碳水化合物中，纖維素、澱粉和糖因其在結合和穩定性方面的重要作用而受到特別關注，而在油脂化學品中，脂醇類、甘油和礦物硬脂酸鹽受到關注，強調其在乳液穩定性和潤滑方面的多方面作用。此外，在石化產品類別中，丙烯酸聚合物、乙二醇、礦物碳氫化合物和聚維酮等元素因其提高產品性能的獨特能力而受到評估。二醇是另一個獨特的子區隔，其中丁二醇、二伸乙甘醇、乙二醇、己二醇、聚乙二醇、微乙二醇和丙二醇經過仔細分析，提供了細微的區別來指南配方選擇。

除了產品類型之外，基於配方的細分還可以透過口服、腸外和局部配方進一步細分市場分析。口服製劑分為硬膠囊、液體製劑、軟膠囊和錠劑，每種製劑根據輸送效率和患者依從性來區分最終用途。功能部分進一步將賦形劑分為粘合劑、被覆劑、著色劑、崩壞、乳化劑、填充劑和稀釋劑、調味劑和甜味劑、助流劑和潤滑劑、防腐劑、懸浮劑和增稠劑。這種分類有助於了解不同的功能如何提高配方效率和最終產品性能。最後，基於最終用戶（例如生物製藥公司、契約製造組織、製藥公司和研究機構）的細分，可以提供有價值的見解，了解誰在推動需求並最終影響產品設計、品管措施和上市策略。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球癌症和其他慢性病及感染疾病發生率不斷上升
      • 製藥業的成長以及對學名藥和罕見疾病藥物的巨大需求
      • 專注於製造多功能輔料
    • 限制因素
      • 生產高級輔料的高成本
    • 機會
      • 賦形劑奈米技術的技術進步
      • 持續研究並開發具有多種特性的賦形劑（生物基）
    • 任務
      • 法規日益嚴格，輔料相容性問題日益增多
  • 市場區隔分析
    • 類型：口服固體製劑中有機輔料的使用增加
    • 配方：明膠殼由於易於吞嚥而越來越受歡迎。
    • 功能：延長錠劑配方中粘合劑的使用，並提供物理和化學保護
    • 最終用戶：生物製藥公司對賦形劑的需求不斷增加，以支援新型藥物輸送系統
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章 藥用輔料市場（按類型）

  • 無機
    • 碳酸鈣
    • 磷酸鈣
    • 硫酸鈣
    • 岩鹽
    • 金屬氧化物
  • 有機的
    • 碳水化合物
      • 纖維素
      • 澱粉
      • 糖
    • 油脂化學品
      • 脂醇類
      • 甘油
      • 礦物硬脂酸鹽
    • 石化產品
      • 丙烯酸聚合物
      • 乙二醇
      • 丁二醇
      • 二伸乙甘醇
      • 乙二醇
      • 己二醇
      • 聚乙二醇
      • 微乙二醇
      • 丙二醇
      • 礦物碳氫化合物
      • 聚維酮
    • 蛋白質

第7章 藥用輔料市場（依配方）

  • 口服製劑
    • 硬明膠膠囊
    • 液體製劑
    • 軟膠囊
    • 藥片
  • 腸外製劑
  • 局部製劑

第8章藥用輔料市場（依功能）

  • 黏合劑
  • 被覆劑
  • 著色劑
  • 崩壞
  • 乳化劑
  • 填充劑和稀釋劑
  • 調味劑和甜味劑
  • 潤滑劑和潤滑劑
  • 防腐劑
  • 懸浮劑和增稠劑

第9章藥用輔料市場（依最終用戶）

  • 生物製藥公司
  • 契約製造組織
  • 製藥公司
  • 研究部門

第 10 章：美洲藥用輔料市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太藥用輔料市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12. 歐洲、中東和非洲藥用輔料市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • ABITEC Corporation
  • Actylis
  • Archer Daniels Midland Company
  • ARMOR PROTEINES SAS by Savencia Group
  • Asahi Kasei Corporation
  • Ashland Inc.
  • BASF SE
  • BIOGRUND GmbH
  • Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
  • Clariant AG
  • Colorcon Inc.
  • Corel Pharma Chem Private Limited
  • Croda International Plc
  • Darling Ingredients, Inc.
  • DFE Pharma GmbH & Co KG by Royal FrieslandCampina NV
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • GATTEFOSSE SAS
  • Innophos Holdings, Inc. by Iris Parent LLC
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH+Co. KG
  • Kerry Group PLC
  • Lipoid GmbH
  • Lubrizol Corporation
  • L'AIR LIQUIDE SA
  • Mallinckrodt plc
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • Nagase & Co., Ltd.
  • Nipon Soda Co., Ltd.
  • NOF Corporation
  • Omya International AG
  • Peter Greven GmbH & Co. KG
  • Roquette Freres SA
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay SA
  • SPI Pharma, Inc.
  • Sumitomo Seika Chemicals Company, Limited
  • Thermo Fisher Scientific Inc.
  • Vanderbilt Minerals LLC
Product Code: MRR-030EE48515E2

The Pharmaceutical Excipient Market was valued at USD 8.62 billion in 2023 and is projected to grow to USD 9.22 billion in 2024, with a CAGR of 7.62%, reaching USD 14.42 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 8.62 billion
Estimated Year [2024] USD 9.22 billion
Forecast Year [2030] USD 14.42 billion
CAGR (%) 7.62%

The pharmaceutical excipient market has evolved into a dynamic and multifaceted ecosystem, reflecting a keen balance between innovation, regulatory compliance, and cost-effective production. In today's competitive landscape, excipients are not mere additives; they are essential agents that impact the efficacy, stability, and overall quality of pharmaceutical formulations. Over the past decade, advancements in material science, a deeper understanding of active pharmaceutical ingredients (API) interactions, and a steady demand for tailored drug delivery systems have spurred robust growth and diversification within the excipient arena.

Manufacturers and researchers alike are leaning into sophisticated processes and quality benchmarks that push beyond the traditional roles of excipients. This development comes at the intersection of technological progress, rigorous standardization protocols, and an increasing emphasis on sustainability. As the market evolves, companies are now tasked with balancing innovation and conforming to strict regulatory controls, ensuring that the end products are both safe and effective. This introduction sets the stage for a comprehensive deep-dive into the trends, segmentation strategies, regional developments, and key company highlights that are defining the current state of the pharmaceutical excipient industry.

Transformative Shifts in the Pharmaceutical Excipient Landscape

The pharmaceutical excipient market is undergoing transformative shifts that are reshaping industry dynamics and redefining best practices. Rapid advancements in biotechnological research coupled with evolving patient-focused demands have catalyzed an environment where excipients are now expected to perform multiple functions beyond their original purpose. Enhanced focus on patient-centric formulations has driven the need for excipients that offer better bioavailability, controlled release properties, and minimized adverse reactions.

Technological breakthroughs in formulation science are enabling manufacturers to blend traditional excipients with novel materials, yielding products that are more adaptable across diverse therapeutic areas. Furthermore, the regulatory environment has become more stringent; agencies worldwide are rigorously enforcing quality and safety benchmarks that make excipient selection a critical component of the development process. This push for higher standards compels manufacturers to innovate continuously and invest in research and development initiatives.

Market players are also experiencing disruptive shifts driven by globalization, where cross-border partnerships and strategic alliances facilitate knowledge exchange and bolster supply chains. With these trends in mind, the market landscape is evolving at a pace that demands immediate attention, strategic partnerships, and agile decision-making processes to harness emerging opportunities.

Key Segmentation Insights Driving Market Nuances

Market segmentation in the pharmaceutical excipient space provides a granular overview of the diverse product offerings and their multiple applications. The segmentation based on type distinguishes between inorganic and organic categories. Inorganic excipients are analyzed further into varieties such as calcium carbonate, calcium phosphate, calcium sulfate, halites, and metal oxides, each with its own set of unique properties that cater to specific formulation needs. Conversely, the organic category is divided into carbohydrates, oleochemicals, petrochemicals, and proteins, demonstrating the importance of both naturally derived and synthetically engineered materials. Carbohydrates are particularly scrutinized in terms of cellulose, starch, and sugars, which play critical roles in binding and stability, while oleochemicals are examined via fatty alcohols, glycerin, and mineral stearates to highlight their multifaceted roles in emulsion stability and lubricity. Additionally, within the petrochemicals category, factors such as acrylic polymers, glycols, mineral hydrocarbons, and povidones are assessed for their unique capabilities in enhancing product performance. Glycols, another distinct sub-segment, are meticulously analyzed across butylene glycol, diethylene glycol, ethylene glycol, hexylene glycol, macrogol, microglycol, and propylene glycol, illustrating the fine distinctions that guide formulation choices.

Beyond product type, segmentation based on formulation further refines market analysis through the lens of oral, parenteral, and topical formulations. Oral formulations are sub-divided into hard gelatin capsules, liquid formulations, soft gelatin capsules, and tablets, each differentiating the end-use based on delivery efficiency and patient compliance. Functional segmentation adds an extra layer of depth by classifying excipients as binders, coating agents, colorants, disintegrants, emulsifying agents, fillers and diluents, flavoring agents and sweeteners, lubricants and glidants, preservatives, and suspending and viscosity agents. This categorization helps understand how different functionalities drive formulation efficiency and final product performance. Finally, segmentation based on end-user-covering biopharmaceutical companies, contract manufacturing organizations, pharmaceutical companies, and research laboratories-provides valuable insights into who is driving demand, ultimately influencing product design, quality control measures, and market deployment strategies.

Based on Type, market is studied across Inorganic and Organic. The Inorganic is further studied across Calcium Carbonate, Calcium Phosphate, Calcium Sulfate, Halites, and Metal Oxides. The Organic is further studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins. The Carbohydrates is further studied across Cellulose, Starch, and Sugars. The Oleochemicals is further studied across Fatty Alcohols, Glycerin, and Mineral Stearates. The Petrochemicals is further studied across Acrylic Polymers, Glycols, Mineral Hydrocarbons, and Povidones. The Glycols is further studied across Butylene Glycol, Diethylene Glycol, Ethylene Glycol, Hexylene Glycol, Macrogol, Microglycol, and Propylene Glycol.

Based on Formulation, market is studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations is further studied across Hard Gelatin Capsules, Liquid Formulations, Soft Gelatin Capsules, and Tablets.

Based on Function, market is studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.

Based on End-User, market is studied across Biopharmaceutical Companies, Contract Manufacturing Organizations, Pharmaceutical Companies, and Research Laboratories.

Key Regional Insights Shaping Market Growth

Regional dynamics play a significant role in shaping the trends and growth drivers of the pharmaceutical excipient market. In the Americas, there is a pronounced focus on innovative drug delivery systems and the enhancement of existing formulations, making it a fertile ground for breakthrough advancements. Meanwhile, the Europe, Middle East & Africa region is characterized by its stringent regulatory framework and emphasis on quality control, which has compelled manufacturers to adopt state-of-the-art production and quality assurance practices. In Asia-Pacific, rapid industrialization combined with an expanding healthcare infrastructure creates a vibrant market fueled by both domestic and international investments.

Each of these regions presents unique challenges and opportunities. For instance, while the Americas benefit from a robust network of research institutions that continuously drive innovation, the Europe, Middle East & Africa segment highlights a commitment to meeting both consumer safety and regulatory standards. Asia-Pacific, on the other hand, is positioned as a crucial hub for scaling production and enabling cost efficiencies. This regional analysis underscores the importance of tailored strategies for each geographical area, ensuring that market participants can effectively align their offerings with specific regional demands and regulatory stipulations.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights in the Pharmaceutical Excipient Sphere

The market is dominated by a robust array of key players, each contributing to the innovation and advancement of pharmaceutical excipients. Notable companies such as ABITEC Corporation, Actylis, and Archer Daniels Midland Company leverage deep industry knowledge and extensive research capabilities to drive product enhancements. Industry leaders like ARMOR PROTEINES S.A.S. by Savencia Group and Asahi Kasei Corporation continue to set benchmarks in quality and regulatory compliance, while Ashland Inc. and BASF SE are recognized for their extensive portfolios and diversified market presence.

Further, key entities such as BIOGRUND GmbH, Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG, and Clariant AG have undertaken significant research investments to ensure that their excipients meet the evolving demands of modern drug formulations. Companies including Colorcon Inc., Corel Pharma Chem Private Limited, and Croda International Plc are continuously exploring innovative applications and derivatives to expand their market influence. The competitive landscape is further enriched by Darling Ingredients, Inc., DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V., and DuPont de Nemours, Inc., whose presence underscores the convergence of scientific excellence and market-driven insights. With additional contributions from Evonik Industries AG, Fuji Chemical Industries Co., Ltd., and GATTEFOSSE SAS among others, the market landscape is defined by a blend of legacy expertise and forward-thinking innovation. This powerful collective of market players is pivotal in steering industry trends and forging collaborations that enhance overall market resilience.

The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Archer Daniels Midland Company, ARMOR PROTEINES S.A.S. by Savencia Group, Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V., DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc. by Iris Parent LLC, International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L'AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, Roquette Freres S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., Sumitomo Seika Chemicals Company, Limited, Thermo Fisher Scientific Inc., and Vanderbilt Minerals LLC. Actionable Recommendations for Industry Leaders

Industry leaders are advised to invest in R&D and embrace innovative formulation technologies to create multifunctional excipients that cater to evolving therapeutic needs. Continuous monitoring of regulatory changes is crucial, and strategies should incorporate agile quality control processes. Companies must explore strategic partnerships to leverage geographic advantages and cost-effective metabolic innovations, while focusing on sustainability initiatives that align with stringent environmental practices. Emphasizing consumer-centric research and adopting digital solutions for real-time quality analytics can offer competitive advantages in a rapidly evolving marketplace.

Conclusion on Emerging Trends and Long-term Prospects

In conclusion, the pharmaceutical excipient market is poised for significant transformation, driven by innovation, enhanced segmentation strategies, and a rigorous regulatory environment. Market players who successfully integrate research innovation with operational agility will be best positioned to capture emerging opportunities and secure long-term growth. The evolving landscape underscores the importance of strategic alignment, continuous investment, and a keen understanding of regional and functional market drivers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
      • 5.1.1.2. Growth of the pharmaceuticals industry coupled with significant need for generics & orphan drugs
      • 5.1.1.3. Significant emphasis on the production of multifunctional excipients
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the production of advanced excipient
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in nanotechnology for excipients
      • 5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing utilization of organic excipients in oral solid dose formulations
    • 5.2.2. Formulation: Rising popularity of gelatin-based shell for ease of swallowing
    • 5.2.3. Function: Expanding utilization of binders in tablet formulations to provide physical and chemical protection
    • 5.2.4. End-User: Rising need for excipients in biopharmaceutical companies to support the novel drug delivery systems
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Excipient Market, by Type

  • 6.1. Introduction
  • 6.2. Inorganic
    • 6.2.1. Calcium Carbonate
    • 6.2.2. Calcium Phosphate
    • 6.2.3. Calcium Sulfate
    • 6.2.4. Halites
    • 6.2.5. Metal Oxides
  • 6.3. Organic
    • 6.3.1. Carbohydrates
      • 6.3.1.1. Cellulose
      • 6.3.1.2. Starch
      • 6.3.1.3. Sugars
    • 6.3.2. Oleochemicals
      • 6.3.2.1. Fatty Alcohols
      • 6.3.2.2. Glycerin
      • 6.3.2.3. Mineral Stearates
    • 6.3.3. Petrochemicals
      • 6.3.3.1. Acrylic Polymers
      • 6.3.3.2. Glycols
      • 6.3.3.2.1. Butylene Glycol
      • 6.3.3.2.2. Diethylene Glycol
      • 6.3.3.2.3. Ethylene Glycol
      • 6.3.3.2.4. Hexylene Glycol
      • 6.3.3.2.5. Macrogol
      • 6.3.3.2.6. Microglycol
      • 6.3.3.2.7. Propylene Glycol
      • 6.3.3.3. Mineral Hydrocarbons
      • 6.3.3.4. Povidones
    • 6.3.4. Proteins

7. Pharmaceutical Excipient Market, by Formulation

  • 7.1. Introduction
  • 7.2. Oral Formulations
    • 7.2.1. Hard Gelatin Capsules
    • 7.2.2. Liquid Formulations
    • 7.2.3. Soft Gelatin Capsules
    • 7.2.4. Tablets
  • 7.3. Parenteral Formulations
  • 7.4. Topical Formulations

8. Pharmaceutical Excipient Market, by Function

  • 8.1. Introduction
  • 8.2. Binders
  • 8.3. Coating Agents
  • 8.4. Colorants
  • 8.5. Disintegrants
  • 8.6. Emulsifying Agents
  • 8.7. Fillers & Diluents
  • 8.8. Flavoring Agents & Sweeteners
  • 8.9. Lubricants & Glidants
  • 8.10. Preservatives
  • 8.11. Suspending & Viscosity Agents

9. Pharmaceutical Excipient Market, by End-User

  • 9.1. Introduction
  • 9.2. Biopharmaceutical Companies
  • 9.3. Contract Manufacturing Organizations
  • 9.4. Pharmaceutical Companies
  • 9.5. Research Laboratories

10. Americas Pharmaceutical Excipient Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmaceutical Excipient Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Excipient Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. GELITA launches endotoxin-controlled excipients portfolio with VACCIPRO and MEDELLAPRO to drive biocompatible innovations
    • 13.3.2. Nucleus Biologics secures EXCiPACT and ISO 9001 certifications to guarantee premium GMP-quality cell culture media and reagents
    • 13.3.3. Nagase Viita to launch SUCROSE SG as an eco-friendly, injectable-grade stabilizer to enhance the stability of biopharmaceuticals
    • 13.3.4. Clariant revolutionizes pharmaceuticals with the launch of high-purity excipients
    • 13.3.5. Shin-Etsu SE Tylose and LBB Specialties forms strategic distribution partnership for cellulose excipients in North and Central America
    • 13.3.6. Evonik's new spray drying facility enhances global supply and sustainability of oral excipients
    • 13.3.7. Roquette's strategic acquisition of IFF Pharma Solutions to bolster global influence in drug delivery solutions and excipients market
    • 13.3.8. Shin-Etsu Chemical to invest JPY 10 billion in expanding global reach of pharmaceutical excipient production
    • 13.3.9. Asahi Kasei enhances pharmaceutical safety with low-nitrite Ceolus MCC excipient and expanded production
    • 13.3.10. Roquette Introduces New Advancement in Moisture Protection
    • 13.3.11. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
    • 13.3.12. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
    • 13.3.13. Lubrizol's Apisolex excipient empowers Welton Pharma to tackle cancer drug solubility challenges
    • 13.3.14. Ingredion leverages strategic acquisitions to strengthen its global pharmaceutical excipient portfolio and enhance offering diversity
    • 13.3.15. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
    • 13.3.16. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
    • 13.3.17. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
    • 13.3.18. Lubrizol Launches Apisolex Technology
    • 13.3.19. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
    • 13.3.20. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Thermo Fisher Scientific Inc.
    • 13.4.2. Archer Daniels Midland Company
    • 13.4.3. Clariant AG
    • 13.4.4. BASF SE

Companies Mentioned

  • 1. ABITEC Corporation
  • 2. Actylis
  • 3. Archer Daniels Midland Company
  • 4. ARMOR PROTEINES S.A.S. by Savencia Group
  • 5. Asahi Kasei Corporation
  • 6. Ashland Inc.
  • 7. BASF SE
  • 8. BIOGRUND GmbH
  • 9. Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
  • 10. Clariant AG
  • 11. Colorcon Inc.
  • 12. Corel Pharma Chem Private Limited
  • 13. Croda International Plc
  • 14. Darling Ingredients, Inc.
  • 15. DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
  • 16. DuPont de Nemours, Inc.
  • 17. Evonik Industries AG
  • 18. Fuji Chemical Industries Co., Ltd.
  • 19. GATTEFOSSE SAS
  • 20. Innophos Holdings, Inc. by Iris Parent LLC
  • 21. International Flavors & Fragrances Inc.
  • 22. JRS PHARMA GmbH + Co. KG
  • 23. Kerry Group P.L.C.
  • 24. Lipoid GmbH
  • 25. Lubrizol Corporation
  • 26. L'AIR LIQUIDE S.A.
  • 27. Mallinckrodt plc
  • 28. MEGGLE GmbH & Co. KG
  • 29. Merck KGaA
  • 30. Nagase & Co., Ltd.
  • 31. Nipon Soda Co., Ltd.
  • 32. NOF Corporation
  • 33. Omya International AG
  • 34. Peter Greven GmbH & Co. KG
  • 35. Roquette Freres S.A.
  • 36. Shin-Etsu Chemical Co., Ltd.
  • 37. Solvay S.A.
  • 38. SPI Pharma, Inc.
  • 39. Sumitomo Seika Chemicals Company, Limited
  • 40. Thermo Fisher Scientific Inc.
  • 41. Vanderbilt Minerals LLC

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL EXCIPIENT MARKET MULTI-CURRENCY
  • FIGURE 2. PHARMACEUTICAL EXCIPIENT MARKET MULTI-LANGUAGE
  • FIGURE 3. PHARMACEUTICAL EXCIPIENT MARKET RESEARCH PROCESS
  • FIGURE 4. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL EXCIPIENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BUTYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DIETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HEXYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MACROGOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MICROGLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROPYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 272. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 291. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 293. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 294. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 295. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 296. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 297. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 298. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 304. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 305. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 306. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 307. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 308. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 309. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 310. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 313. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 315. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 316. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 317. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 318. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 319. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 320. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 321. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 322. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 323. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 324. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 326. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 327. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 328. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 329. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 330. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 331. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 332. FRANCE PHARMACEUTICAL EX